Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

IBC 293

From Wikipedia, the free encyclopedia

IBC 293
Identifiers
  • 1-propan-2-ylbenzotriazole-5-carboxylic acid
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC10H11N3O2
Molar mass205.217 g·mol−1
3D model (JSmol)
  • CC(C)N1C2=C(C=C(C=C2)C(=O)O)N=N1
  • InChI=1S/C10H11N3O2/c1-6(2)13-9-4-3-7(10(14)15)5-8(9)11-12-13/h3-6H,1-2H3,(H,14,15)
  • Key:RUTVRAJKELSHCC-UHFFFAOYSA-N

IBC 293 is an experimental drug which acts as a potent and selective agonist for the Hydroxycarboxylic acid receptor 3 (GPR109B), with good selectivity over the closely related HCA2/GPR109A receptor. It is used for studying the function of this receptor, and has been shown to activate neutrophils, demonstrating a role for HCA3 in immune system function.[1][2][3]

References

[edit]
  1. Semple G, Skinner PJ, Cherrier MC, Webb PJ, Sage CR, Tamura SY, et al. (February 2006). "1-Alkyl-benzotriazole-5-carboxylic acids are highly selective agonists of the human orphan G-protein-coupled receptor GPR109b". Journal of Medicinal Chemistry. 49 (4): 1227–1230. doi:10.1021/jm051099t. PMID 16480258.
  2. Boatman PD, Richman JG, Semple G (December 2008). "Nicotinic acid receptor agonists". Journal of Medicinal Chemistry. 51 (24): 7653–7662. doi:10.1021/jm800896z. PMID 18983141.
  3. Forsman H, Li W, Levin NK, Karlsson R, Karlsson A, Dahlgren C, et al. (June 2025). "Activation and signaling characteristics of the hydroxy-carboxylic acid 3 receptor identified in human neutrophils through a microfluidic flow cell technique". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1872 (5) 119950. doi:10.1016/j.bbamcr.2025.119950. PMID 40194600.